Why the study?
Does flecainide cause His-Purkinje system reentry tachycardia in patients with underlying HPS disease?
Does flecainide cause His-Purkinje system reentry tachycardia in patients with underlying HPS disease?
Flecainide may induce proarrhythmic effects, specifically reentry within the His-Purkinje system, in patients with underlying conduction disease.
Answers are grounded in this paper and cite their sources.
Flecainide may induce His-Purkinje reentry in conduction disease; leaves open causality and needs prospective confirmation.
We report a case of tachycardia due to reentry within the His-Purkinje system (HPS) occurring after introduction of flecainide. The patient presented with a mild mitral regurgitation and normal left ventricular function. He had incomplete left bundle branch block with left-axis deviation. At the electrophysiology study, a prolonged HV interval was observed at baseline, and the tachycardia could be reproduced after ajmaline infusion. Six months after interruption of flecainide, the patient remains free of arrhythmia recurrence. The authors emphasize that proarrhythmic effects of flecainide may include reentry within the HPS in patients with underlying HPS disease.
No takes yet. Share an insight, caveat, or question.
Chalvidan et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: